Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 175

Similar articles for PubMed (Select 24196337)

1.
2.
3.

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles.

Swanson N, Abramovits W, Berman B, Kulp J, Rigel DS, Levy S.

J Am Acad Dermatol. 2010 Apr;62(4):582-90. doi: 10.1016/j.jaad.2009.07.004. Epub 2010 Feb 4.

PMID:
20133013
4.

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles.

Hanke CW, Beer KR, Stockfleth E, Wu J, Rosen T, Levy S.

J Am Acad Dermatol. 2010 Apr;62(4):573-81. doi: 10.1016/j.jaad.2009.06.020. Epub 2010 Feb 4.

PMID:
20133012
5.

Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials.

Lebwohl M, Dinehart S, Whiting D, Lee PK, Tawfik N, Jorizzo J, Lee JH, Fox TL.

J Am Acad Dermatol. 2004 May;50(5):714-21.

PMID:
15097955
6.

Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial.

Gebauer K, Shumack S, Cowen PS.

Br J Dermatol. 2009 Oct;161(4):897-903. doi: 10.1111/j.1365-2133.2009.09260.x. Epub 2009 May 26.

PMID:
19545297
7.
8.

A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses.

Stockfleth E, Meyer T, Benninghoff B, Salasche S, Papadopoulos L, Ulrich C, Christophers E.

Arch Dermatol. 2002 Nov;138(11):1498-502.

PMID:
12437457
9.

Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream.

Lee PK, Harwell WB, Loven KH, Phillips TJ, Whiting DA, Andres KL, Lee JH.

Dermatol Surg. 2005 Jun;31(6):659-64.

PMID:
15996416
10.

Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology.

Szeimies RM, Gerritsen MJ, Gupta G, Ortonne JP, Serresi S, Bichel J, Lee JH, Fox TL, Alomar A.

J Am Acad Dermatol. 2004 Oct;51(4):547-55.

PMID:
15389189
12.
13.

A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses.

Jorizzo JL, Markowitz O, Lebwohl MG, Bourcier M, Kulp J, Meng TC, Levy S.

J Drugs Dermatol. 2010 Sep;9(9):1101-8.

PMID:
20865842
14.

Imiquimod 3.75% cream (Zyclara) for the treatment of actinic keratoses.

Quist SR, Gollnick HP.

Expert Opin Pharmacother. 2011 Feb;12(3):451-61. doi: 10.1517/14656566.2011.549128. Review.

PMID:
21254950
15.
16.

Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms.

Harrison LI, Skinner SL, Marbury TC, Owens ML, Kurup S, McKane S, Greene RJ.

Arch Dermatol Res. 2004 Jun;296(1):6-11. Epub 2004 Apr 9.

PMID:
15083310
18.
19.
20.

Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial.

Ooi T, Barnetson RS, Zhuang L, McKane S, Lee JH, Slade HB, Halliday GM.

Br J Dermatol. 2006 Jan;154(1):72-8.

PMID:
16403097
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk